Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs17059951 | chr18:74539699 | C/T | 5.36E-5 | 178 | 25.47 | 25.52 | 18.63 | KM Plot |
PCPG | rs17118403 | chr12:56630067 | C/T | 9.68E-8 | 178 | 25.17 | 29.13 | 0.8 | KM Plot |
PCPG | rs17118409 | chr12:56630764 | G/A | 9.68E-8 | 178 | 25.17 | 29.13 | 0.8 | KM Plot |
PCPG | rs17118431 | chr12:56667100 | A/G | 1.09E-7 | 177 | 25.17 | 27.33 | 0.8 | KM Plot |
PCPG | rs17118439 | chr12:56667604 | C/T | 1.53E-5 | 178 | 2.73 | 29.13 | 25.35 | KM Plot |
PCPG | rs17135499 | chr16:1759794 | C/T | 4.68E-5 | 178 | 17.77 | 18.75 | 25.47 | KM Plot |
PCPG | rs17135500 | chr16:1759853 | A/G | 5.3E-5 | 176 | 25.47 | 18.75 | 17.77 | KM Plot |
PCPG | rs17135502 | chr16:1764942 | T/C | 6.54E-5 | 174 | 25.6 | 15.85 | 17.77 | KM Plot |
PCPG | rs17135503 | chr16:1777493 | A/G | 2.24E-11 | 170 | 25.17 | 27.27 | 4.52 | KM Plot |
PCPG | rs17172272 | chr7:36155691 | T/C | 0.000433 | 178 | 25.77 | 24.5 | 14.37 | KM Plot |
PCPG | rs17172273 | chr7:36168209 | G/A | 0.000452 | 176 | 25.87 | 24.37 | 14.37 | KM Plot |
PCPG | rs17177891 | chr16:89799950 | C/T | 0.000194 | 173 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs17182656 | chr14:74351313 | C/T | 1.14E-5 | 175 | 25.28 | 28.3 | 10.43 | KM Plot |
PCPG | rs17182675 | chr14:74378805 | A/G | 1.16E-5 | 176 | 25.4 | 27.2 | 10.43 | KM Plot |
PCPG | rs17182783 | chr14:74571874 | G/A | 2.24E-5 | 176 | 25.4 | 27.43 | 10.3 | KM Plot |